Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation

INTRODUCTION: Prospective studies on rivaroxaban and apixaban have shown the safety and efficacy of direct anticoagulation agents (DOAC)s used peri-procedurally during radiofrequency ablation (RFA) of atrial fibrillation (AF). Studies comparing the two agents have not been performed. METHODS: Consec...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Indian Pacing Electrophysiol J
Glavni autori: Pillarisetti, Jayasree, Reddy, Madhu, Vodapally, Mamatha, Annapureddy, Tulasi, Molugu, Maruthsakhi, Atkins, Donita, Bommana, Sudharani, Pimentel, Rhea, Dendi, Raghuveer, Lakkireddy, Dhanunjaya
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Practice Guidelines
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7691779/
https://ncbi.nlm.nih.gov/pubmed/32810538
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ipej.2020.08.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items